Immune Checkpoint Inhibitors and Radiotherapy in NSCLC Patients: Not Just a Fluke

by Belluomini, Lorenzo, Fiorica, Francesco, Frassoldati, Antonio
Published in Oncol Ther (2019)

Synchronous Papillary Carcinoma and Hemangiopericytoma with Lung Metastases

by Malagutti, Nicola, Iannini, Valeria, Rocchi, Andrea, Stomeo, Francesco, Frassoldati, Antonio, Borin, Michela, Pelucchi, Stefano
Published 2013

Impressive Response to Dose-Dense Chemotherapy in a Patient with NUT Midline Carcinoma

by Maur, Michela, Toss, Angela, Dominici, Massimo, Frassoldati, Antonio, Corradini, Paolo, Maiorana, Antonio, Fontana, Annalisa, Conte, Pierfranco
Published in Am J Case Rep (2015)

Patient and Health Care Professional Perspectives: A Case Study of the Lung Cancer Integrated Care Pathway

by Bravi, Francesca, Ruscio, Eugenio Di, Frassoldati, Antonio, Cavallesco, Giorgio Narciso, Valpiani, Giorgia, Ferrozzi, Anna, Wienand, Ulrich, Carradori, Tiziano
Published in Int J Integr Care (2018)

Fighting cancer in coronavirus disease era: organization of work in medical oncology departments in Emilia Romagna region of Italy

by Brandes, Alba A, Ardizzoni, Andrea, Artioli, Fabrizio, Cappuzzo, Federico, Cavanna, Luigi, Frassineti, Giovanni Luca, Frassoldati, Antonio, Leonardi, Francesco, Longo, Giuseppe, Maestri, Antonio, Tassinari, Davide, Franceschi, Enrico, Nunno, Vincenzo Di, Pinto, Carmine
Published in Future Oncol (2020)

Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer

by Griguolo, Gaia, Dieci, Maria Vittoria, Paré, Laia, Miglietta, Federica, Generali, Daniele Giulio, Frassoldati, Antonio, Cavanna, Luigi, Bisagni, Giancarlo, Piacentini, Federico, Tagliafico, Enrico, Cagossi, Katia, Ficarra, Guido, Prat, Aleix, Conte, Pierfranco, Guarneri, Valentina
Published in NPJ Breast Cancer (2021)

A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC

by Del Re, Marzia, Cucchiara, Federico, Rofi, Eleonora, Fontanelli, Lorenzo, Petrini, Iacopo, Gri, Nicole, Pasquini, Giulia, Rizzo, Mimma, Gabelloni, Michela, Belluomini, Lorenzo, Crucitta, Stefania, Ciampi, Raffaele, Frassoldati, Antonio, Neri, Emanuele, Porta, Camillo, Danesi, Romano
Published in Cancer Immunol Immunother (2020)

Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)

by Gelsomino, Francesco, Tiseo, Marcello, Barbieri, Fausto, Riccardi, Ferdinando, Cavanna, Luigi, Frassoldati, Antonio, Delmonte, Angelo, Longo, Lucia, Dazzi, Claudio, Cinieri, Saverio, Colantonio, Ida, Sperandi, Francesca, Lamberti, Giuseppe, Brocchi, Stefano, Tofani, Lorenzo, Boni, Luca, Ardizzoni, Andrea
Published in Br J Cancer (2020)

Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)

by Gelsomino, Francesco, Tiseo, Marcello, Barbieri, Fausto, Riccardi, Ferdinando, Cavanna, Luigi, Frassoldati, Antonio, Delmonte, Angelo, Longo, Lucia, Dazzi, Claudio, Cinieri, Saverio, Colantonio, Ida, Sperandi, Francesca, Lamberti, Giuseppe, Brocchi, Stefano, Tofani, Lorenzo, Boni, Luca, Ardizzoni, Andrea
Published in Br J Cancer (2021)

Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for...

by Guarneri, Valentina, Dieci, Maria Vittoria, Frassoldati, Antonio, Maiorana, Antonino, Ficarra, Guido, Bettelli, Stefania, Tagliafico, Enrico, Bicciato, Silvio, Generali, Daniele Giulio, Cagossi, Katia, Bisagni, Giancarlo, Sarti, Samanta, Musolino, Antonino, Ellis, Catherine, Crescenzo, Rocco, Conte, PierFranco
Published in Oncologist (2015)

Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatment

by Del Re, Marzia, Bordi, Paola, Petrini, Iacopo, Rofi, Eleonora, Mazzoni, Francesca, Belluomini, Lorenzo, Vasile, Enrico, Restante, Giuliana, Di Costanzo, Francesco, Falcone, Alfredo, Frassoldati, Antonio, van Schaik, Ron H.N., Steendam, Christi M.J., Chella, Antonio, Tiseo, Marcello, Morganti, Riccardo, Danesi, Romano
Published in Oncotarget (2017)

Liquid Biopsy Testing Can Improve Selection of Advanced Non-Small-Cell Lung Cancer Patients to Rechallenge with Gefitinib

by Esposito Abate, Riziero, Pasquale, Raffaella, Sacco, Alessandra, Piccirillo, Maria Carmela, Morabito, Alessandro, Bidoli, Paolo, Finocchiaro, Giovanna, Chiari, Rita, Foltran, Luisa, Buosi, Roberta, Tiseo, Marcello, Giannetta, Laura, Battiloro, Ciro, Fasola, Gianpiero, Romano, Gianpiero, Ciuffreda, Libero, Frassoldati, Antonio, de Marinis, Filippo, Cappuzzo, Federico, Normanno, Nicola
Published in Cancers (Basel) (2019)

Observational study on quality of life, safety, and effectiveness of first‐line cetuximab plus chemotherapy in KRAS wild‐type metastatic colorectal cancer patients: the ObservEr St...

by Pinto, Carmine, Di Fabio, Francesca, Rosati, Gerardo, Lolli, Ivan R., Ruggeri, Enzo M., Ciuffreda, Libero, Ferrari, Daris, Lo Re, Giovanni, Rosti, Giovanni, Tralongo, Paolo, Ferrara, Raimondo, Alabiso, Oscar, Chiara, Silvana, Ianniello, Giovanni P., Frassoldati, Antonio, Bilancia, Domenico, Campanella, Giovanna A., Signorelli, Carlo, Racca, Patrizia, Benincasa, Elena, Stroppolo, Maria Elena, Di Costanzo, Francesco
Published in Cancer Med (2016)

Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting

by Generali, Daniele, Montemurro, Filippo, Bordonaro, Roberto, Mafodda, Antonino, Romito, Sante, Michelotti, Andrea, Piovano, Pierluigi, Ionta, Maria Teresa, Bighin, Claudia, Sartori, Donata, Frassoldati, Antonio, Cazzaniga, Marina Elena, Riccardi, Ferdinando, Testore, Franco, Vici, Patrizia, Barone, Carlo Antonio, Schirone, Alessio, Piacentini, Federico, Nolè, Franco, Molino, Annamaria, Latini, Luciano, Simoncini, Edda Lucia, Roila, Fausto, Cognetti, Francesco, Nuzzo, Francesco, Foglietta, Jennifer, Minisini, Alessandro Marco, Goffredo, Francesca, Portera, Giuseppe, Ascione, Gilda, Mariani, Gabriella
Published in Oncologist (2017)

Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial

by Dieci, Maria Vittoria, Bisagni, Giancarlo, Brandes, Alba A., Frassoldati, Antonio, Cavanna, Luigi, Giotta, Francesco, Aieta, Michele, Gebbia, Vittorio, Musolino, Antonino, Garrone, Ornella, Donadio, Michela, Rimanti, Anita, Beano, Alessandra, Zamagni, Claudio, Soto Parra, Hector, Piacentini, Federico, Danese, Saverio, Ferro, Antonella, Cagossi, Katia, Sarti, Samanta, Gambaro, Anna Rita, Romito, Sante, Bazan, Viviana, Amaducci, Laura, Moretti, Gabriella, Foschini, Maria Pia, Balduzzi, Sara, Vicini, Roberto, D’Amico, Roberto, Griguolo, Gaia, Guarneri, Valentina, Conte, Pier Franco
Published in BMC Med (2019)

The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer

by Gori, Stefania, Inno, Alessandro, Fiorio, Elena, Foglietta, Jennifer, Ferro, Antonella, Gulisano, Marcella, Pinotti, Graziella, Gubiotti, Marta, Cavazzini, Maria Giovanna, Turazza, Monica, Duranti, Simona, De Simone, Valeria, Iezzi, Laura, Bisagni, Giancarlo, Spazzapan, Simon, Cavanna, Luigi, Saggia, Chiara, Bria, Emilio, Cretella, Elisabetta, Vici, Patrizia, Santini, Daniele, Fabi, Alessandra, Garrone, Ornella, Frassoldati, Antonio, Amaducci, Laura, Saracchini, Silvana, Evangelisti, Lucia, Barni, Sandro, Gamucci, Teresa, Mentuccia, Lucia, Laudadio, Lucio, Zoboli, Alessandra, Marchetti, Fabiana, Bogina, Giuseppe, Lunardi, Gianluigi, Boni, Luca
Published in PLoS One (2015)

Correction: The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer

by Gori, Stefania, Inno, Alessandro, Fiorio, Elena, Foglietta, Jennifer, Ferro, Antonella, Gulisano, Marcella, Pinotti, Graziella, Gubiotti, Marta, Cavazzini, Maria Giovanna, Turazza, Monica, Duranti, Simona, De Simone, Valeria, Iezzi, Laura, Bisagni, Giancarlo, Spazzapan, Simon, Cavanna, Luigi, Saggia, Chiara, Bria, Emilio, Cretella, Elisabetta, Vici, Patrizia, Santini, Daniele, Fabi, Alessandra, Garrone, Ornella, Frassoldati, Antonio, Amaducci, Laura, Saracchini, Silvana, Evangelisti, Lucia, Barni, Sandro, Gamucci, Teresa, Mentuccia, Lucia, Laudadio, Lucio, Zoboli, Alessandra, Marchetti, Fabiana, Bogina, Giuseppe, Lunardi, Gianluigi, Boni, Luca
Published in PLoS One (2015)

“Triple positive” early breast cancer: an observational multicenter retrospective analysis of outcome

by Vici, Patrizia, Pizzuti, Laura, Sperduti, Isabella, Frassoldati, Antonio, Natoli, Clara, Gamucci, Teresa, Tomao, Silverio, Michelotti, Andrea, Moscetti, Luca, Gori, Stefania, Baldini, Editta, Giotta, Francesco, Cassano, Alessandra, Santini, Daniele, Giannarelli, Diana, Di Lauro, Luigi, Corsi, Domenico Cristiano, Marchetti, Paolo, Sini, Valentina, Sergi, Domenico, Barba, Maddalena, Maugeri-Saccà, Marcello, Russillo, Michelangelo, Mentuccia, Lucia, D'Onofrio, Loretta, Iezzi, Laura, Scinto, Angelo Fedele, Da Ros, Lucia, Bertolini, Ilaria, Basile, Maria Luisa, Rossi, Valentina, De Maria, Ruggero, Montemurro, Filippo
Published in Oncotarget (2016)

Correction 2: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

by Cazzaniga, Marina, Verusio, Claudio, Ciccarese, Mariangela, Fumagalli, Alberto, Sartori, Donata, Valerio, Maria Rosaria, Airoldi, Mario, Moretti, Gabriella, Ficorella, Corrado, Arcangeli, Valentina, Diodati, Lucrezia, Zambelli, Alberto, Febbraro, Antonio, Generali, Daniele, Pistelli, Mirco, Garrone, Ornella, Musolino, Antonino, Vici, Patrizia, Maur, Michela, Mentuccia, Lucia, La Verde, Nicla, Bianchi, Giulia, Artale, Salvatore, Blasi, Livio, Piezzo, Michela, Atzori, Francesco, Turletti, Anna, Benedetto, Chiara, Cursano, Maria Concetta, Fabi, Alessandra, Gebbia, Vittorio, Schirone, Alessio, Palumbo, Raffaella, Ferzi, Antonella, Frassoldati, Antonio, Scavelli, Claudio, Clivio, Luca, Torri, Valter
Published in Oncotarget (2018)

Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

by Cazzaniga, Marina, Verusio, Claudio, Ciccarese, Mariangela, Fumagalli, Alberto, Sartori, Donata, Ancona, Cristina, Airoldi, Mario, Moretti, Gabriella, Ficorella, Corrado, Arcangeli, Valentina, Diodati, Lucrezia, Zambelli, Alberto, Febbraro, Antonio, Generali, Daniele, Pistelli, Mirco, Garrone, Ornella, Musolino, Antonino, Vici, Patrizia, Maur, Michela, Mentuccia, Lucia, La Verde, Nicla, Bianchi, Giulia, Artale, Salvatore, Blasi, Livio, Piezzo, Matilde, Atzori, Francesco, Turletti, Anna, Benedetto, Chiara, Cursano, Maria Concetta, Fabi, Alessandra, Gebbia, Vittorio, Schirone, Antonio, Palumbo, Raffaella, Ferzi, Antonella, Frassoldati, Antonio, Scavelli, Claudio, Clivio, Luca, Torri on behalf of The EVA Study Group, Valter
Published in Oncotarget (2018)